Cost-effectiveness of prehabilitation prior to elective surgery: a systematic review of economic evaluations

por Rombey, Tanja, Eckhardt, Helene, Kiselev, Jörn, Silzle, Julia, Mathes, Tim, Quentin, Wilm
Publicado 2023

The first-in-class alkylating HDAC inhibitor EDO-S101 is highly synergistic with proteasome inhibition against multiple myeloma through activation of multiple pathways

por Besse, L, Kraus, M, Besse, A, Bader, J, Silzle, T, Mehrling, T, Driessen, C
Publicado 2017

P1053: ALBUMIN AND C-REACTIVE PROTEIN PROVIDE PROGNOSTIC INFORMATION INDEPENDENTLY FROM MIPSS70 IN OVERT MYELOFIBROSIS. A RETROSPECTIVE STUDY.

por Messerich, N.-M., Volken, T., Cogliatti, S., Lehmann, T., Holbro, A., Demmer, I., Benz, R., Jochum, W., Silzle, T.
Publicado 2022

Humoral and cellular responses to mRNA-based COVID-19 booster vaccinations in patients with solid neoplasms under active treatment

por Su, E., S. Fischer, R. Demmer-Steingruber, Nigg, S., Güsewell, S., Albrich, W.C., Rothermundt, C., Silzle, T., Kahlert, C.R.
Publicado 2022

Lymphopenia at diagnosis is highly prevalent in myelodysplastic syndromes and has an independent negative prognostic value in IPSS-R-low-risk patients

por Silzle, Tobias, Blum, Sabine, Schuler, Esther, Kaivers, Jennifer, Rudelius, Martina, Hildebrandt, Barbara, Gattermann, Norbert, Haas, Rainer, Germing, Ulrich
Publicado 2019

The Absolute Monocyte Count at Diagnosis Affects Prognosis in Myelodysplastic Syndromes Independently of the IPSS-R Risk Score

por Silzle, Tobias, Blum, Sabine, Kasprzak, Annika, Nachtkamp, Kathrin, Rudelius, Martina, Hildebrandt, Barbara, Götze, Katharina S., Gattermann, Norbert, Lauseker, Michael, Germing, Ulrich
Publicado 2023

PB2060: THE MDS-SPECIFIC COMORBIDITY INDEX (MDS-CI) PREDICTS SURVIVAL INDEPENDENTLY FROM DIPSS AND MIPSS70 IN PATIENTS WITH OVERT MYELOFIBROSIS NOT ELIGIBLE FOR ALLOGENEIC STEM CEL...

por Koster, K.-L., Messerich, N.-M., Volken, T., Cogliatti, S., Lehmann, T., Holbro, A., Benz, R., Graf, L., Demmer, I., Jochum, W., Silzle, T.
Publicado 2022

Nelfinavir and lenalidomide/dexamethasone in patients with lenalidomide-refractory multiple myeloma. A phase I/II Trial (SAKK 39/10)

por Hitz, F., Kraus, M., Pabst, T., Hess, D., Besse, L., Silzle, T., Novak, U., Seipel, K., Rondeau, S., Stüdeli, S., Vilei, S. Berardi, Samaras, P., Mey, U., Driessen, C.
Publicado 2019

Prognostic Significance of the Myelodysplastic Syndrome-Specific Comorbidity Index (MDS-CI) in Patients with Myelofibrosis: A Retrospective Study

por Koster, Kira-Lee, Messerich, Nora-Medea, Volken, Thomas, Cogliatti, Sergio, Lehmann, Thomas, Graf, Lukas, Holbro, Andreas, Benz, Rudolf, Demmer, Izadora, Jochum, Wolfram, Rao, Tata Nageswara, Silzle, Tobias
Publicado 2023

CRP/Albumin Ratio and Glasgow Prognostic Score Provide Prognostic Information in Myelofibrosis Independently of MIPSS70—A Retrospective Study

por Messerich, Nora-Medea, Uda, Narasimha Rao, Volken, Thomas, Cogliatti, Sergio, Lehmann, Thomas, Holbro, Andreas, Benz, Rudolf, Graf, Lukas, Gupta, Vikas, Jochum, Wolfram, Demmer, Izadora, Rao, Tata Nageswara, Silzle, Tobias
Publicado 2023

Effectiveness of chatbots on COVID vaccine confidence and acceptance in Thailand, Hong Kong, and Singapore

por Lee, Kristi Yoonsup, Dabak, Saudamini Vishwanath, Kong, Vivian Hanxiao, Park, Minah, Kwok, Shirley L. L., Silzle, Madison, Rachatan, Chayapat, Cook, Alex, Passanante, Aly, Pertwee, Ed, Wu, Zhengdong, Elkin, Javier A., Larson, Heidi J., Lau, Eric H. Y., Leung, Kathy, Wu, Joseph T., Lin, Leesa
Publicado 2023